Interleukin-13 Counteracts Suppression Induced by Interleukin-1β of Glucose Metabolism but not of Insulin Secretion in Rat Pancreatic Islets

References

• Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619–633
   PubMed Web of Science ®Google Scholar
• Eisenbarth G. S. Type T diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986; 314: 1360–1368
   PubMed Web of Science ®Google Scholar
• Nakhooda A. F., Like A. A., Chappel C. I., Wei C. N., Marliss E. B. The spontaneously diabetic Wistar rat (the “BB” rat). Studies prior to and during development of the overt syndrome. Diabetologia 1978; 14: 199–207
   PubMed Web of Science ®Google Scholar
• Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., Tochino Y. Breeding of a nonobese, diabetic strain of mice. Exp Anim 1980; 29: 1–13
   PubMedGoogle Scholar
• Nerup J., Mandrup-Poulsen T., Mølvig J. The HLA-IDDM association: implications for etiology and pathogenesis of 1DDM. Diabetes Metab Rev 1987; 3: 779–802
   PubMed Web of Science ®Google Scholar
• Rabinovitch A. Roles of cytokines in IDDM pathogenesis and islet β-cell destruction. Diabetes Rev 1993; 1: 215–240
   Google Scholar
• Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 1996; 39: 1005–1029
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T., Bendtzen K., Nerup J., Dinarello C. A., Svenson M., Nielsen J. H. Affinity-purified human inlerleukin 1 is cytotoxic to isolated islets of Langerhans. Diabetologia 1986; 29: 63–67
   PubMed Web of Science ®Google Scholar
• Bendtzen K., Mandrup-Poulsen T., Nerup J., Nielsen J. H., Dinarello C. A., Svenson M. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 1986; 232: 1545–1547
   PubMed Web of Science ®Google Scholar
• Sandler S., Andersson A., Hellerström C. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 1987; 121: 1424–1431
   PubMed Web of Science ®Google Scholar
• Sandler S., Bendtzen K., Borg L. A., Eizirik D. L., Strandell E., Welsh N. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function. Endocrinology 1989; 124: 1492–1501
   PubMed Web of Science ®Google Scholar
• Southern C., Schulster D., Green I. C. Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 1990; 276: 42–44
   PubMed Web of Science ®Google Scholar
• Welsh N., Eizirik D. L., Bendtzen K., Sandler S. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 1991; 129: 3167–3173
   PubMed Web of Science ®Google Scholar
• Corbett J. A., Lancaster J. R., Jr, Sweetland M. A., McDaniel M. L. Interleukin-1β-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion. J Biol Chem 1991; 266: 21351–21354
   PubMed Web of Science ®Google Scholar
• Corbett J. A., Wang J. L., Hughes J. H., Wolf B. A., Sweetland M. A., Lancaster J. R., Jr, et al. Nitric oxide and cyclic GMP formation induced by interleukin I beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Biochem J 1992; 287: 229–235
   PubMed Web of Science ®Google Scholar
• Sandler S., Sternesjö J. Interleukin 4 impairs rat pancreatic islet function in vitro by an action different to that of interleukin 1. Cytokine 1995; 7: 296–300
   PubMed Web of Science ®Google Scholar
• Doherty T. M., Kastelein R., Menon S., Andrade S., Coffman R. L. Modulation of murine macrophage function by IL-13. J Immunol 1993; 151: 7151–7160
   PubMed Web of Science ®Google Scholar
• Doyle A. G., Herbein G., Montaner L. J., Minty A. J., Caput D., Ferrara P., et al. Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma. Eur J Immunol 1994; 24: 1441–1445
   PubMed Web of Science ®Google Scholar
• Saura M., Martinez D. R., Minty A., Perez S. D., Lamas S. Interleukin-13 inhibits inducible nitric oxide synthase expression in human mesangial cells. Biochem J 1996; 313: 641–646
   PubMed Web of Science ®Google Scholar
• Cocks B. C, de W. M. R., Galizzi J. P., de V. J., Aversa G. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol 1993; 5: 657–663
   PubMed Web of Science ®Google Scholar
• Krebs H. A., Henseleit K. Untersuchungen über die Harnstoffbildung im Tierkörper. Hoppe-Seylers Z Physiol Chem 1932; 210: 33–66
   Google Scholar
• Heding L. G. Determination of total serum insulin (1RI) in insulin-treated diabetic patients. Diabetologia 1972; 8: 260–266
   PubMed Web of Science ®Google Scholar
• Kissane J. M., Robins E. The fluorometric mesurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J Biol Chem 1958; 233: 184–188
   PubMed Web of Science ®Google Scholar
• Hinegardner R. T. An improved fluorometric assay for DNA. AnalBiochem 1971; 39: 197–201
   PubMed Web of Science ®Google Scholar
• Keen H., Field J. B., Pastan I. H. A simple method for in vivo metabolic studies using small volumes of tissue and medium. Metabolism 1963; 12: 143–147
   PubMed Web of Science ®Google Scholar
• Andersson A., Sandler S. Viability tests of cryopreserved endocrine pancreatic cells. Cryobiology 1983; 20: 161–168
   PubMed Web of Science ®Google Scholar
• Green L. C, Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131–138
   PubMed Web of Science ®Google Scholar
• Welsh N., Sandler S. Protective action by hemin against interleukin-1 beta induced inhibition of rat pancreatic islet function. Mol Cell Endocrinol 1994; 103: 109–114
   PubMed Web of Science ®Google Scholar
• Eizirik D. L., Sandler S., Welsh N., Cetkovic C. M., Nieman A., Geller D. A., et al. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 1994; 93: 1968–1974
   PubMed Web of Science ®Google Scholar
• Rabinovitch A., Suarez-Pinzon W., Strynadka K., Schulz R., Lakey J. R., Warnock G. L., et al. Human pancreatic islet beta-cell destruction by cytokines is independent of nitric oxide production. J Clin Endocrinol Metab 1994; 79: 1058–1062
   PubMed Web of Science ®Google Scholar
• Dunger A., Cunningham J. M., Delaney C. A., Lowe I E., Green M. H., Bone A. J., et al. Tumor necrosis factor-alpha and interferon-gamma inhibit insulin secretion and cause DNA damage in unweaned-rat islets. Extent of nitric oxide involvement. Diabetes 1996; 45: 183–189
   PubMed Web of Science ®Google Scholar
• Lefort S., Vita N., Reeb R., Caput D., Ferrara P. IL-13 and IL-4 share signal transduction elements as well as receptor components in TF-1 cells. FEBS Lett 1995; 366: 122–126
   PubMed Web of Science ®Google Scholar
• Keegan A. D., Johnston J. A., Tortolani P. J., McRey-Nolds L. J., Kinzer C., O'Shea J. J., et al. ). Similar-ities and differences in signal transduction by interleukin 4 and interleukin 13: analysis of Janus kinase activation. Proc Natl Acad Sci USA 1995; 92: 7681–7685
   PubMed Web of Science ®Google Scholar
• Sakamoto O., Hashiyama M., Minty A., Ando M., Suda T. Interleukin-13 selectively suppresses the growth of human macrophage progenitors at the late stage. Blood 1995; 85: 3487–3493
   PubMed Web of Science ®Google Scholar
• Jacobsen S. E., Okkenhaug C., Veiby O. P., Caput D., Ferrara P., Minty A. Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J Exp Med 1994; 180: 75–82
   PubMed Web of Science ®Google Scholar